Ankle Cartilage Lesions (Osteochondral Defects): Regenerative Repair Options
Medically reviewed by Dr. Charles Pereyra, MD — Medical Director, Springs Rejuvenation. Last reviewed June 24, 2026.
Written by the Springs Rejuvenation regenerative medicine team from direct clinical experience administering stem cell and exosome protocols at our Aventura, Miami center.
An osteochondral lesion of the ankle — damage to a small area of cartilage and the bone beneath it — often follows a bad sprain or fracture and can cause deep, persistent ankle pain that imaging finally explains. Patients want to know whether regenerative approaches can help repair the area without major surgery. The honest answer depends heavily on the size and stability of the lesion.
What an osteochondral lesion is
Cartilage caps the bone surfaces inside the ankle joint, and an osteochondral lesion involves both the cartilage and a patch of the bone underneath. Because cartilage has no direct blood supply and bone supports on its own timeline, these lesions can be slow and unpredictable to recover — which is exactly why biological approaches are studied here.
What regenerative options aim to do
Cell-based and exosome approaches aim to support the joint and tissue environment around the lesion rather than mechanically rebuild the surface. At Springs Rejuvenation these are considered for the right lesion and delivered as part of a broader plan, with a clear-eyed assessment of whether the defect is small and stable enough to be a reasonable candidate.
Reading the evidence honestly
Research on biologic augmentation for cartilage lesions is active and evolving, with some studies reporting improved outcomes when regenerative support is combined with appropriate procedures. The fair framing is that regenerative therapy may have a supportive role for selected smaller lesions, while large, unstable, or displaced lesions frequently require a surgical solution. Matching the approach to the lesion is essential.
Who tends to be a candidate?
Patients with smaller, stable lesions and reasonable joint health are the most plausible fit for a regenerative-supported plan. Large or unstable lesions usually warrant a surgical opinion, and we will say so directly.
Can this avoid surgery entirely?
For some smaller lesions it may be part of a conservative attempt, but it is not a guaranteed alternative to surgery, and results vary.
How is the lesion assessed?
Detailed imaging clarifies the size and stability of the lesion, which guides every decision that follows.
The Springs approach
We evaluate the lesion carefully, set honest expectations, and recommend a regenerative plan only when the defect and the evidence support it. A free consultation is the simplest way to understand your options.
Medical Disclaimer: Stem cell and exosome therapy is not an FDA approved therapy and is considered to be in the experimental stages. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Springs Rejuvenation processes exosomes in an FDA approved lab. Individual results may vary. This content is reviewed for medical accuracy by Dr. Charles Pereyra, MD, Medical Director of Springs Rejuvenation, and is provided for educational purposes only. Always consult a qualified physician.